Literature DB >> 19641473

Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer.

Ann G Schwartz1, Michele L Cote, Angela S Wenzlaff, Susan Land, Christopher I Amos.   

Abstract

INTRODUCTION: Three genome-wide association studies identified a region on chromosome 15q25.1 associated with lung cancer and measures of nicotine addiction. This region includes nicotinic acetylcholine receptor subunit genes CHRNA3 and CHRNA5. These studies were conducted in European or European American populations and do not provide risk estimates for African Americans. The goal of this study was to determine whether recently identified genetic variation in 3 SNPs (rs1051730, rs931794, rs8034191) on chromosome 15q25.1 contributes to risk of lung cancer in African Americans.
METHODS: Data were derived from three case-control studies. Participants included 1058 population-based non-small cell lung cancer cases selected from the Detroit area SEER registry and 1314 controls matched within study by age, race, and sex. Thirty-nine percent of participants were African American.
RESULTS: Risk associated with rs1051730 (odds ratio 1.59; 95% confidence interval 1.16-2.19) and rs931794 (odds ratio 1.39; 95% confidence interval 1.09-1.78) increased in ever smoking African Americans adjusting for cigarettes smoked per day. Among white cases, the number of cigarettes smoked varied by genotype at all three SNPs, and when smoking quantity was included in the models, risk was not significantly associated with any of the three SNPs.
CONCLUSIONS: These findings suggest that SNPs in the CHRNA3 and CHRNA5 region contribute to lung cancer risk, and while variant alleles are less frequent in African Americans, risk in this group may be greater than in whites and less likely to reflect an indirect effect on lung cancer risk through nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19641473      PMCID: PMC3768000          DOI: 10.1097/JTO.0b013e3181b244ef

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  22 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.

Authors:  A S Wenzlaff; M L Cote; C H Bock; S J Land; A G Schwartz
Journal:  Carcinogenesis       Date:  2004-11-04       Impact factor: 4.944

3.  Variants in nicotinic receptors and risk for nicotine dependence.

Authors:  Laura Jean Bierut; Jerry A Stitzel; Jen C Wang; Anthony L Hinrichs; Richard A Grucza; Xiaoling Xuei; Nancy L Saccone; Scott F Saccone; Sarah Bertelsen; Louis Fox; William J Horton; Naomi Breslau; John Budde; C Robert Cloninger; Danielle M Dick; Tatiana Foroud; Dorothy Hatsukami; Victor Hesselbrock; Eric O Johnson; John Kramer; Samuel Kuperman; Pamela A F Madden; Kevin Mayo; John Nurnberger; Ovide Pomerleau; Bernice Porjesz; Oliver Reyes; Marc Schuckit; Gary Swan; Jay A Tischfield; Howard J Edenberg; John P Rice; Alison M Goate
Journal:  Am J Psychiatry       Date:  2008-06-02       Impact factor: 18.112

4.  The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.

Authors:  Margaret R Spitz; Christopher I Amos; Qiong Dong; Jie Lin; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2008-10-28       Impact factor: 13.506

5.  Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.

Authors:  Pengyuan Liu; Haris G Vikis; Daolong Wang; Yan Lu; Yian Wang; Ann G Schwartz; Susan M Pinney; Ping Yang; Mariza de Andrade; Gloria M Petersen; Jonathan S Wiest; Pamela R Fain; Adi Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Teresa Coons; Juwon Lee; Elena Kupert; Daniela Seminara; John Minna; Joan E Bailey-Wilson; Xifeng Wu; Margaret R Spitz; Timothy Eisen; Richard S Houlston; Christopher I Amos; Marshall W Anderson; Ming You
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

6.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

7.  Opioids induce while nicotine suppresses apoptosis in human lung cancer cells.

Authors:  R Maneckjee; J D Minna
Journal:  Cell Growth Differ       Date:  1994-10

8.  Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.

Authors:  Loïc Le Marchand; Kiersten S Derby; Sharon E Murphy; Stephen S Hecht; Dorothy Hatsukami; Steven G Carmella; Maarit Tiirikainen; Hansong Wang
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

9.  Nicotinic receptor gene variants influence susceptibility to heavy smoking.

Authors:  Victoria L Stevens; Laura J Bierut; Jeffrey T Talbot; Jen C Wang; Juzhong Sun; Anthony L Hinrichs; Michael J Thun; Alison Goate; Eugenia E Calle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11-24       Impact factor: 4.254

10.  Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese.

Authors:  Kouya Shiraishi; Takashi Kohno; Hideo Kunitoh; Shun-ichi Watanabe; Koichi Goto; Yutaka Nishiwaki; Yoko Shimada; Hiroshi Hirose; Ikuo Saito; Aya Kuchiba; Seiichro Yamamoto; Jun Yokota
Journal:  Carcinogenesis       Date:  2008-11-12       Impact factor: 4.944

View more
  43 in total

1.  Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.

Authors:  Manuela Gago-Dominguez; Xuejuan Jiang; David V Conti; Jose Esteban Castelao; Mariana C Stern; Victoria K Cortessis; Malcolm C Pike; Yong-Bing Xiang; Yu-Tang Gao; Jian-Min Yuan; David J Van Den Berg
Journal:  Carcinogenesis       Date:  2010-11-15       Impact factor: 4.944

2.  Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.

Authors:  Krista A Zanetti; Zhaoming Wang; Melinda Aldrich; Christopher I Amos; William J Blot; Elise D Bowman; Laurie Burdette; Qiuyin Cai; Neil Caporaso; Charles C Chung; Elizabeth M Gillanders; Christopher A Haiman; Helen M Hansen; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Shengchao Li; Lorna Haughton McNeill; Bríd M Ryan; Ann G Schwartz; Jennette D Sison; Margaret R Spitz; Margaret Tucker; Angela S Wenzlaff; John K Wiencke; Lynne Wilkens; Margaret R Wrensch; Xifeng Wu; Wei Zheng; Weiyin Zhou; David Christiani; Julie R Palmer; Trevor M Penning; Alyssa G Rieber; Lynn Rosenberg; Edward A Ruiz-Narvaez; Li Su; Anil Vachani; Yongyue Wei; Alexander S Whitehead; Stephen J Chanock; Curtis C Harris
Journal:  Lung Cancer       Date:  2016-05-13       Impact factor: 5.705

3.  Quantitative assessment of the influence of common variations (rs8034191 and rs1051730) at 15q25 and lung cancer risk.

Authors:  Bin Hu; Ying Huang; Rong-huan Yu; Hong-ju Mao; Chao Guan; Jing Zhao
Journal:  Tumour Biol       Date:  2013-11-20

4.  Germline Genetic Variants and Lung Cancer Survival in African Americans.

Authors:  Carissa C Jones; William S Bush; Dana C Crawford; Angela S Wenzlaff; Ann G Schwartz; John K Wiencke; Margaret R Wrensch; William J Blot; Stephen J Chanock; Eric L Grogan; Melinda C Aldrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-15       Impact factor: 4.254

5.  Racial Disparities in Lung Cancer Survival: The Contribution of Stage, Treatment, and Ancestry.

Authors:  Carissa C Jones; Sarah Fletcher Mercaldo; Jeffrey D Blume; Angela S Wenzlaff; Ann G Schwartz; Heidi Chen; Stephen A Deppen; William S Bush; Dana C Crawford; Stephen J Chanock; William J Blot; Eric L Grogan; Melinda C Aldrich
Journal:  J Thorac Oncol       Date:  2018-06-06       Impact factor: 15.609

6.  Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers.

Authors:  Lori C Sakoda; Melissa M Loomis; Jennifer A Doherty; Marian L Neuhouser; Matt J Barnett; Mark D Thornquist; Noel S Weiss; Gary E Goodman; Chu Chen
Journal:  Cancer Causes Control       Date:  2011-01-13       Impact factor: 2.506

Review 7.  Germline mutations predisposing to non-small cell lung cancer.

Authors:  Gerald H Clamon; Aaron D Bossler; Taher Abu Hejleh; Muhammad Furqan
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

8.  Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans.

Authors:  Kyle M Walsh; Ivan P Gorlov; Helen M Hansen; Xifeng Wu; Margaret R Spitz; Huifeng Zhang; Emily Y Lu; Angela S Wenzlaff; Jennette D Sison; Chongjuan Wei; Stacy M Lloyd; Wei Chen; Marsha L Frazier; Michael F Seldin; Laura J Bierut; Paige M Bracci; Margaret R Wrensch; Ann G Schwartz; John K Wiencke; Christopher I Amos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-05       Impact factor: 4.254

9.  Role of selected genetic variants in lung cancer risk in African Americans.

Authors:  Margaret R Spitz; Christopher I Amos; Susan Land; Xifeng Wu; Qiong Dong; Angela S Wenzlaff; Ann G Schwartz
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

10.  Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.

Authors:  Nancy L Saccone; Robert C Culverhouse; Tae-Hwi Schwantes-An; Dale S Cannon; Xiangning Chen; Sven Cichon; Ina Giegling; Shizhong Han; Younghun Han; Kaisu Keskitalo-Vuokko; Xiangyang Kong; Maria Teresa Landi; Jennie Z Ma; Susan E Short; Sarah H Stephens; Victoria L Stevens; Lingwei Sun; Yufei Wang; Angela S Wenzlaff; Steven H Aggen; Naomi Breslau; Peter Broderick; Nilanjan Chatterjee; Jingchun Chen; Andrew C Heath; Markku Heliövaara; Nicole R Hoft; David J Hunter; Majken K Jensen; Nicholas G Martin; Grant W Montgomery; Tianhua Niu; Thomas J Payne; Leena Peltonen; Michele L Pergadia; John P Rice; Richard Sherva; Margaret R Spitz; Juzhong Sun; Jen C Wang; Robert B Weiss; William Wheeler; Stephanie H Witt; Bao-Zhu Yang; Neil E Caporaso; Marissa A Ehringer; Tim Eisen; Susan M Gapstur; Joel Gelernter; Richard Houlston; Jaakko Kaprio; Kenneth S Kendler; Peter Kraft; Mark F Leppert; Ming D Li; Pamela A F Madden; Markus M Nöthen; Sreekumar Pillai; Marcella Rietschel; Dan Rujescu; Ann Schwartz; Christopher I Amos; Laura J Bierut
Journal:  PLoS Genet       Date:  2010-08-05       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.